MARC details
| 000 -LEADER |
|---|
| campo de control de longitud fija |
04208cam a2200385 i 4500 |
| 001 - NÚMERO DE CONTROL |
|---|
| campo de control |
21433505 |
| 003 - IDENTIFICADOR DE NÚMERO DE CONTROL |
|---|
| campo de control |
BJBSDDR |
| 005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN |
|---|
| campo de control |
20230411090801.0 |
| 007 - CAMPO FIJO DE DESCRIPCIÓN FÍSICA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
ta |
| 008 - DATOS DE LONGITUD FIJA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
200214t20202020nyuaf b 001 0 eng |
| 010 ## - NÚMERO DE CONTROL DE LA BIBLIOTECA DEL CONGRESO |
|---|
| Número de control de LC |
2019300476 |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| Número Internacional Estándar del Libro |
9780525431992 |
| Información calificativa |
(pbk) |
| 040 ## - FUENTE DE CATALOGACIÓN |
|---|
| Centro catalogador/agencia de origen |
DLC |
| Lengua de catalogación |
eng |
| Normas de descripción |
rda |
| Centro/agencia transcriptor |
DLC |
| Centro/agencia modificador |
DLC |
| 042 ## - CÓDIGO DE AUTENTICACIÓN |
|---|
| Código de autenticación |
pcc |
| 043 ## - CÓDIGO DE ÁREA GEOGRÁFICA |
|---|
| Código de área geográfica |
n-us--- |
| 050 00 - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO |
|---|
| Número de clasificación |
HD9995.H423 |
| Número de ítem |
U627 2020 |
| 082 00 - NÚMERO DE LA CLASIFICACIÓN DECIMAL DEWEY |
|---|
| Número de clasificación |
338.7/681761 |
| Número de edición |
23 |
| 100 ## - ENTRADA PRINCIPAL--NOMBRE DE PERSONA |
|---|
| Nombre de persona |
Carreyrou, Johr |
| Término indicativo de función/relación |
author. |
| 9 (RLIN) |
23697 |
| 245 10 - MENCIÓN DEL TÍTULO |
|---|
| Título |
Bad blood : |
| Resto del título |
secrets and lies in a Silicon Valley Startup / |
| Mención de responsabilidad, etc. |
John Carreyrou. |
| 250 ## - MENCION DE EDICION |
|---|
| Mención de edición |
First Vintage Books Edition. |
| 264 #1 - PRODUCCIÓN, PUBLICACIÓN, DISTRIBUCIÓN, FABRICACIÓN Y COPYRIGHT |
|---|
| Producción, publicación, distribución, fabricación y copyright |
New York : |
| Nombre del de productor, editor, distribuidor, fabricante |
Vintage Books, a division of Penguin Random House LLC, |
| Fecha de producción, publicación, distribución, fabricación o copyright |
2020. |
| 300 ## - DESCRIPCIÓN FÍSICA |
|---|
| Extensión |
341 pages, 8 unnumbered pages of plates : |
| Otras características físicas |
ill ; |
| Dimensiones |
21 cm |
| 336 ## - TIPO DE CONTENIDO |
|---|
| Término de tipo de contenido |
text |
| Código de tipo de contenido |
txt |
| Fuente |
rdacontent |
| 337 ## - TIPO DE MEDIO |
|---|
| Nombre/término del tipo de medio |
unmediated |
| Código del tipo de medio |
n |
| Fuente |
rdamedia |
| 338 ## - TIPO DE SOPORTE |
|---|
| Nombre/término del tipo de soporte |
volume |
| Código del tipo de soporte |
nc |
| Fuente |
rdacarrier |
| 504 ## - NOTA DE BIBLIOGRAFÍA, ETC. |
|---|
| Nota de bibliografía, etc. |
Includes bibliographical references (pages 307-326) and index. |
| 520 ## - RESUMEN, ETC. |
|---|
| Sumario, etc. |
"The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"-- |
| Fuente proveedora |
Provided by publisher. |
| 520 ## - RESUMEN, ETC. |
|---|
| Sumario, etc. |
"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"-- |
| Fuente proveedora |
Provided by publisher. |
| 610 20 - PUNTO DE ACCESO ADICIONAL DE MATERIA--NOMBRE DE ENTIDAD CORPORATIVA |
|---|
| Nombre de entidad corporativa o nombre de jurisdicción como elemento de entrada |
Theranos (Firm) |
| Subdivisión general |
History. |
| 650 #0 - PUNTO DE ACCESO ADICIONAL DE MATERIA--TÉRMINO DE MATERIA |
|---|
| Término de materia o nombre geográfico como elemento de entrada |
Hematologic equipment industry |
| Subdivisión geográfica |
United States. |
| 650 #0 - PUNTO DE ACCESO ADICIONAL DE MATERIA--TÉRMINO DE MATERIA |
|---|
| Término de materia o nombre geográfico como elemento de entrada |
Fraud |
| Subdivisión geográfica |
United States. |
| 906 ## - ELEMENTOS DE DATOS F LOCAL, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
origcop |
| d |
2 |
| e |
ncip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ELEMENTOS DE ENTRADA SECUNDARIOS (KOHA) |
|---|
| Fuente del sistema de clasificación o colocación |
Clasificación de Library of Congress |
| Tipo de ítem Koha |
Libro |
